Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs): A Post-Market Study

NCT06212427 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT06212427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs): A Post-Market Study
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2023
Completion date
February 28, 2026
Enrollment
188 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

low birthweight infant, premature infant